were used. Mice were injected with SKF 38393 or apomorphine, 10 min later with r-butyrolactone (750 mg/ kg, i.p.), and a further 5 min later with 3 hydroxybenzylhydrazine (100 mg/kg, i.p.) to inhibit aromatic amino acid decarboxylase. Mice were killed by decapitation 30 min after the treatment with the decarboxylase inhibitor. The striata were dissected out after removal of the brain, homogenized in 1 ml of 0.25 N perchloric acid containing 0.2 iiM EDTA and 40 ng of 3,4-dihydroxybenzyl amine as an internal standard. DOPA and catecholamines were extracted with alumina and assayed using H PLC with electrochemical detection (9, 10). Each value represents the mean±S.E.M. DOPA levels after 3-hydroxybenzylhydrazine treatment were 1.61 ±0.08 pg/g (N=1 2). N=number of experiments. **P<0.01, compared with the r-butyrolactone control. regulate the DA synthesis in the striatum are not D-1 but D-2 type. On the other hand, it has been reported that evoked-release of 3H-DA from the striatum in vitro is inhibited by D-2 receptor agonists, but not by a D-1 receptor agonist (6, 7) and suggested that the release-inhibiting DA autoreceptors are also the D-2 type.
Taking these results into consideration, the D-1 type of autoreceptors located on dopaminergic nerve terminals, if any, appears not to be involved in the regulation of DA synthesis. In our preliminary experiment, we have shown an involvement of postsynaptic D-1 receptors in the regulation mediated by the striato-nigral feedback loop of DA release from the striatum studied by the in vivo dialysis method (H. Watanabe et al. unpublished observation).
The functional role of D-1 receptors is not known, but the receptors seem to have some relation to the mobilization of a second messenger system including A kinase through the activation of adenylate cyclase (21).
